FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4407311000001101: Prostin E2 2mg vaginal gel (Pfizer Ltd) 2.5 ml (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
26358301000001113 Prostin E2 2mg vaginal gel (Pfizer Ltd) 2.5 ml (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
26358401000001117 Prostin E2 2mg vaginal gel (Pfizer Ltd) 2.5 ml en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prostin E2 2mg vaginal gel (Pfizer Ltd) 2.5 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Prostin E2 2mg vaginal gel (Pfizer Ltd) 2.5 ml Is a Dinoprostone 800micrograms/ml vaginal gel 2.5 ml true Inferred relationship Existential restriction modifier
Prostin E2 2mg vaginal gel (Pfizer Ltd) 2.5 ml Is pack of Prostin E2 2mg vaginal gel (Pfizer Ltd) false Inferred relationship Existential restriction modifier
Prostin E2 2mg vaginal gel (Pfizer Ltd) 2.5 ml Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Prostin E2 2mg vaginal gel (Pfizer Ltd) 2.5 ml Has active ingredient Alprostadil false Inferred relationship Existential restriction modifier
Prostin E2 2mg vaginal gel (Pfizer Ltd) 2.5 ml Has active ingredient Posterior pituitary hormone false Inferred relationship Existential restriction modifier
Prostin E2 2mg vaginal gel (Pfizer Ltd) 2.5 ml Has active ingredient Dinoprostone false Inferred relationship Existential restriction modifier
Prostin E2 2mg vaginal gel (Pfizer Ltd) 2.5 ml Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Prostin E2 2mg vaginal gel (Pfizer Ltd) 2.5 ml Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Prostin E2 2mg vaginal gel (Pfizer Ltd) 2.5 ml Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Prostin E2 2mg vaginal gel (Pfizer Ltd) 2.5 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Prostin E2 2mg vaginal gel (Pfizer Ltd) 2.5 ml VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Prostin E2 2mg vaginal gel (Pfizer Ltd) 2.5 ml Has manufactured dose form Gel false Inferred relationship Existential restriction modifier
Prostin E2 2mg vaginal gel (Pfizer Ltd) 2.5 ml Has AMP Prostin E2 2mg vaginal gel (Pfizer Ltd) true Inferred relationship Existential restriction modifier
Prostin E2 2mg vaginal gel (Pfizer Ltd) 2.5 ml Has specific active ingredient Dinoprostone true Inferred relationship Existential restriction modifier
Prostin E2 2mg vaginal gel (Pfizer Ltd) 2.5 ml Has dispensed dose form Gel false Inferred relationship Existential restriction modifier
Prostin E2 2mg vaginal gel (Pfizer Ltd) 2.5 ml Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Prostin E2 2mg vaginal gel (Pfizer Ltd) 2.5 ml Has dispensed dose form Conventional release vaginal gel true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start